Search clinical trials for: DOXIL/CAELYX
Total 233 results
-
OrganogenesisTerminatedGingival RecessionUnited States
-
Spanish Breast Cancer Research GroupSchering-PloughCompleted
-
Mural Oncology, IncMerck Sharp & Dohme LLCRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Taiwan, Canada, Israel, France, United Kingdom, Germany, Belgium, Czechia, Singapore, Australia, Austria, Italy
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Verastem, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingLow Grade Serous Ovarian CancerUnited States, Australia
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Stage IV Breast Cancer AJCC...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMetastatic Breast CancerUnited States
-
SOLTI Breast Cancer Research GroupSchering-PloughCompleted
-
MedtradeCharite University, Berlin, GermanyNot yet recruitingPostpartum Hemorrhage
-
University of RegensburgEssex Pharma GermanyCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCCompleted
-
Calypso Biotech BVCompletedCeliac Disease | Eosinophilic EsophagitisNetherlands, Belgium, Finland, Germany, Norway
-
Cardiochirurgia E.H.Terminated
-
PfizerCompletedOvarian CancerUnited States, Canada, Australia, France, Israel, Spain, United Kingdom, Korea, Republic of, Taiwan, Austria, Denmark, Hungary, Singapore, Hong Kong, Belgium, Japan, Ireland, Italy, Netherlands, Czechia, Poland, Switzerland, Russian... and more
-
Patrick ReaganSeagen Inc.Active, not recruitingDiffuse Large B-Cell LymphomaUnited States
-
University of ArizonaTerminatedBreast CancerUnited States
-
Millennium Pharmaceuticals, Inc.WithdrawnOvarian CancerItaly, Switzerland
-
National Cancer Institute (NCI)CompletedDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Shenzhen Kangzhe Pharmaceutical Co., Ltd.Hunan Cancer Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University and other collaboratorsRecruitingBreast Cancer | Ovarian CancerChina
-
SCRI Development Innovations, LLCGlaxoSmithKlineTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CarcinomaUnited States
-
Université de SherbrookeRecruitingGlioblastoma Multiforme | RelapseCanada
-
Novo Nordisk A/SCompletedCancer | Ovarian CancerGermany, France
-
University of MalayaNDR Medical Technology Pte LtdNot yet recruiting
-
Weiyun AiCelgene CorporationCompletedLymphoma | T-Cell Lymphoma | Cutaneous LymphomaUnited States
-
OncotherapeuticsCelgene CorporationCompletedMultiple MyelomaUnited States
-
Hacettepe UniversityActive, not recruiting
-
University of Witten/HerdeckeTerminated
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedSarcoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ortho Biotech, Inc.Completed
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin LymphomaUnited States
-
Vejle HospitalCompletedEpithelial Ovarian CancerDenmark, Belgium, Sweden, Austria
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseTerminatedOvarian CancerUnited States
-
Mario Negri Institute for Pharmacological ResearchPharmaMar; Averion International CorporationCompletedOvarian CancerAustria, Belgium, Norway, Spain, Finland, United Kingdom, Italy, Denmark, Germany, Netherlands, Switzerland
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Breast Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Hellenic Oncology Research GroupUniversity Hospital of CreteTerminated
-
ARCAGY/ GINECO GROUPCompleted
-
CelgeneGynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USATerminatedMetastatic Breast CancerUnited States
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Recruiting
-
Joseph TuscanoMillennium Pharmaceuticals, Inc.CompletedAcute Myelogenous LeukemiaUnited States
-
University Hospital, Basel, SwitzerlandCompleted
-
Theodore LaetschWithdrawnSarcoma | Osteosarcoma | Sarcoma, Ewing | Neuroblastoma | Rhabdomyosarcoma | DesmoidUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCWithdrawnStudy of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Roswell Park Cancer InstituteEisai Inc.CompletedRecurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube CancerUnited States